试剂基团反应特点（Reagent group reaction characteristics）：
DOTA-cyclo(RGDfK)螯合剂多肽，RGD肽是指含有由Arg-Gly-Asp三个氨基酸组成的序列多肽，有直线肽和环肽之分。它们是许多细胞外基质蛋白（如VN、FN、FGN、胶原等）等小识别短肽序列。RGD作为某些整合素的受体，其选择性部分依赖于RGD的构象以及RGD周围的氨基酸残基。

DOTA cycle (RGDfK) chelating agent peptide, RGD peptide refers to a sequence peptide composed of Arg Gly Asp three amino acids, which can be divided into linear peptide and cyclic peptide. They are small recognition short peptide sequences of many extracellular matrix proteins (such as VN, FN, FGN, collagen, etc.). As a receptor for certain integrins, the selectivity of RGD partially depends on the conformation of RGD and the amino acid residues around RGD.

（文章资料汇总来源于：陕西新研博美生物科技有限公司小编MISSwu）​

基础产品数据（Basic Product Data）：
CAS号：N/A
英文名：DOTA-cyclo(RGDfK)，DOTA-c(RGDfK)
结构式（Structural）：

详细产品数据（Detailed Product Data）：
Molecular formula：C43H67N13O14
Molecular weight：989.09
Purity standard：95%+，具体的试剂可以在线进行咨询
Storage conditions：At 20 ℃, in a cool, dry and well ventilated warehouse
Packaging specification：1g、5g、10g等（Customized packaging will be carried out according to the situation）
Solubility：Soluble in most organic solvents, such as DCM, DMF, DMSO, THF, etc., with good solubility in water）
In stock：SCommunicate with suppliers

Precautions：Keep a dry environment when using, and avoid frequent thawing for freezing.

试剂系列产品（Reagent series products）：
Cyclo(-Hyp-Gly)
CTTHWGFTLC, CYCLIC
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid(ACI)
(R)-tert-Bu4-DOTAGA
FAPI-4-NH2
PSMA I&T,DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu)
FAP-2286
DOTA-E-[cyclo(RGDfK(Acp))]2
cyclo(RGDFK(DOTA)）
Cyclo[(D-Tyr)-(D-NMe-Orn)-Arg-(2-Nal)-Gly] [Cyclo(D-Tyr)
DOTA-cyclo(RGDfK) acetate
DOTA-cyclo(RGDyK)
DOTA-E[c(RGDfK)2]
DOTA-cyclo(RGDfK)
DOTA-E[c(RGDyK)2]
Exendin-4
DOTA-MeTz  DOTA-甲基四嗪
DOTA-DBCO
DOTA-PEG4-MeTz   DOTA-四聚乙二醇-甲基四嗪
DOTA-PEG5-DBCO
DOTA-PEG5-azide
温馨提示：所有的试剂仅用于科研实验。
今日分享的文章包含DOTA-cyclo(RGDfK)试剂相关物理数据，化学式，CAS号，反应特点，以及相应的结构式，有相关疑问的朋友，欢迎关注收藏，为大家答疑解惑，进行交流。